发明名称 Method and kit for rapid isolation of human Foxp3+ Treg cells
摘要 The present invention relates to methods for isolating human forkhead box P3 (Foxp3+) CD4+ regulatory T cells (herein referred to a Foxp3+ Treg cells) from a sample containing (i) peripheral blood mononuclear cells (PBMCs), (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue, a kit for isolating human Foxp3+ Treg cells, and the use of anti-CD49d antibody for the isolation of human Foxp3+ Treg cells.
申请公布号 US9213028(B2) 申请公布日期 2015.12.15
申请号 US201314089179 申请日期 2013.11.25
申请人 MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (MDC) 发明人 Roetzschke Olaf;Falk Kirsten;Kleinewietfeld Markus
分类号 C12N5/071;G01N33/535;G01N33/569;C12N5/0783;A61K35/12 主分类号 C12N5/071
代理机构 Licata & Tyrrell P.C. 代理人 Licata & Tyrrell P.C.
主权项 1. A method for isolating human Foxp3+ regulatory T cells by negative selection comprising (a) treating a sample containing (i) peripheral blood mononuclear cells, (ii) a lymphocyte containing fluid, or (iii) a lymphocyte containing tissue with antibodies, wherein said antibodies consist of an anti-CD49d antibody and an anti-CD127 antibody; and (b) depleting the sample of CD49+ and CD127+ cells via the anti-CD49d antibody and anti-CD127 antibody to obtain an enriched population of label- and antibody-free Foxp3+ regulatory T cells.
地址 Berlin DE
您可能感兴趣的专利